The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy.
Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine’s October issue.
Bacteria are good at mutating to become resistant to antibiotics. As one way to combat the problem of antimicrobial resistance, the Centers for Disease Control and Prevention (CDC) has called for the development of novel diagnostics to detect and help manage the treatment of infectious diseases.
“We really lack tools in the clinic to be able to visualize bacterial infections,” explains Sanjiv Sam Gambhir, MD, PhD, chair of the Radiology Department and director of Precision Health and Integrated Diagnostics at Stanford University in California. “What we need is something that bacteria eat that your cells, so-called mammalian cells, do not. As it turns out, there is such an agent, and that agent is maltose, which is taken up only by bacteria because they have a transporter, called a maltodextrine transporter, on their cell wall that is able to take up maltose and small derivatives of maltose.”
The traditional way of diagnosing bacterial infection involves biopsy of the infected tissue and/or blood and culture tests. Gambhir and colleagues developed a new positron emission tomography (PET) tracer, 6?-18F-fluoromaltotriose, that offers a non-invasive means of detection. The agent is a derivative of maltose and is labeled with radioactive fluorine-18 (18F). For this study, the tracer was evaluated in several clinically relevant bacterial strains in cultures and in mouse models using a micro-PET/CT scanner. Its use to help monitor antibiotic therapies was also evaluated in rats.
The results show that 6?-18F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains, and it was able to detect Pseudomonas aeruginosa in a clinically relevant mouse model of wound infection.
Gambhir points out, “This is the first time this particular maltotriose, labeled with fluorine-18, has been synthesized and used in animal models. It’s able to pick up bacteria that may be present anywhere throughout your body, and it does not lead to an imaging signal from a site of infection that does not involve bacteria.”
He notes that the new agent even identified an infection in the heart of an animal. “We could pick up very small bacterial foci in a heart valve. And then when those animals were treated with an antibiotic, we could see that the signal went away in the heart. So, the properties of the tracer of sensitivity, specificity, low background signal throughout the animal are now facilitating its translation into humans.”
The results of this pre-clinical study demonstrate that 6?-18F-fluoromaltotriose is a promising new tracer for diagnosing most bacterial infections and has the potential to change the clinical management of patients suffering from infectious diseases of bacterial origin.
Looking ahead, Gambhir says, “The hope is that in the future when someone has a potential infection, this approach of injecting the patient with fluoromaltotriose and imaging them in a PET scanner will allow localization of the signal and, therefore, the bacteria. And then, as one treats them, one can verify that the treatment is actually working—so that if it’s not working, one can quickly change to a different treatment (for example, a different antibiotic). These kinds of findings are very important for patients, because they will very likely lead to entirely new ways to manage patients with bacterial infections, no matter where those infections might be hiding in the body.”
The Latest on: Bacterial infections
- Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infectionon September 17, 2019 at 6:11 am
Inovio is advancing a ground-breaking approach to combat multidrug-resistant infections based on ... antibody specifically targeting the bacteria. Inovio's dMAbs can be developed simply and ...
- Fungal Eye Infection Market 2019- Global Industry Size, Growth, Trends, Analysis by Top Key Players and Forecast to 2023on September 17, 2019 at 3:55 am
The Americas dominate the global fungal eye infection market owing to the presence of population suffering from a fungal and bacterial infection and increasing number of surgical procedures in the ...
- Along with destruction, hurricanes can bring diseases and infection | Opinionon September 17, 2019 at 3:05 am
Broken skin is also vulnerable to (1) leptospirosis, if floodwaters are contaminated with animal urine; these bacteria can also enter the body if contaminated water enters through the eyes, nose, or ...
- Higher hospital-wide use of antibiotics linked to more C. difficile infectionson September 16, 2019 at 7:52 pm
difficile. The four high-risk classes were cephalosporins (used for a wide variety of bacterial infections), fluoroquinolones (used for respiratory and urinary tract infections), carbapenems (broad ...
- VERIFY: Does blue water in the Gulf of Mexico mean less flesh-eating bacteria?on September 16, 2019 at 4:40 pm
RELATED: Central Texas girl, 10, dies after contracting brain-eating amoeba infection while swimming While water color may not influence the amount of flesh-eating bacteria, water temperature does.
- Dr. Is In: Bacterial Endocarditison September 16, 2019 at 4:54 am
Bacterial Endocarditis is an infection of the lining of the heart. It generally happens on heart valves that are damaged or replaced. The bacteria will eat through the lining of the valve. Treatment ...
- Salivary Gland Infection Market Size, Share, Key Drivers, Restraints, Opportunities and Challenges Affecting the Growth By 2023on September 16, 2019 at 4:00 am
WOCKHARDT's a global pharmaceutical and biotechnology organization is under clinical development of its Second-generation Ketolide drug which can treat serious bacterial infections. Salivary Gland ...
- Adenovirus infection is associated with altered gut microbial communities in a non-human primateon September 16, 2019 at 3:13 am
If AdV-infections disturb the gut bacterial homeostasis, resulting in the loss of commensal bacteria and/or increase in pathobionts, this could promote co-infections and possibly increase previously ...
- Study: Seafood Safety at Risk Due to Antibiotic-Resistant Bacterial Strainson September 15, 2019 at 5:01 pm
The highest prevalence of resistance was found to erythromycin, an antibiotic used to treat a wide range of bacterial infections. Although the study focused on dolphins, researchers also noted an ...
- Potomac River exposure causes cases of infectionon September 13, 2019 at 6:00 pm
Most people with that strain of bacteria recover within three days, with no lasting problems. However, cases of vibrio vulnificus—the type of infection seen locally—can get seriously ill and need ...
via Google News and Bing News